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Abstract
Obesity is often associated with multiple other clinical conditions, including hypertension and
cardiovascular disease. Currently, more than one-third of the world’s population is classified as
obese. Leptin is a neuropeptide that is released from adipose cells and is responsible for reducing
appetite and increasing metabolism. Leptin also has a role in the activation of cardiovascular and
metabolic pre-sympathetic neurons and has been reported to increase blood pressure and heart rate.
Thus, understanding the activation of the autonomic nervous system by leptin has implications in
the development and safety of drugs to avoid activation of cardiovascular pre-sympathetic neurons.
This is important because a drug that causes an increase in blood pressure or heart rate would not
be effective in diminishing cardiovascular-related comorbidities. This study tests the hypothesis
that intracerebroventricular leptin activates sympathetic metabolically-related neurons in the
hypothalamus. To identify leptin receptor-expressing neurons, we created a colony of transgenic
reporter mice expressing tdTomato in the presence of the leptin receptor (ObRb) gene. To
determine if treatment with leptin activated sympathetic metabolically-related neurons, we
performed neuroanatomical tracer studies in the mice. The metabolically-related neurons were
identified by microinjection of green FluoSpheres (505/515) into medullary raphe nucleus which
is considered to be the sympathetic metabolic regulatory output center. After microinjection,
hypothalamic neurons that express green Fluosphere project to the raphe and therefore are
considered metabolic. To identify neuronal activation, we stained for cells expressing c-fos. We
found that intracerebroventricular leptin activates hypothalamic neurons, however c-fos positive
neurons were not retrogradely labelled raphe-projecting sympathetic metabolic neurons.
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Chapter One
Introduction
Metabolic syndrome is a term used to describe the presence of multiple cardiac risk factors
including abdominal obesity, dyslipidemia, hyperglycemia, and hypertension. Metabolic
syndrome has an average prevalence of 31% worldwide [1]. People who have metabolic syndrome
have an increased risk of type 2 diabetes and a twofold risk of cardiovascular disease when it is
paired with abdominal obesity [2]. The need for a treatment for metabolic syndrome and the
conditions associated with it is evident. To develop better treatments, there is a need to understand
the neuronal pathways that are associated with obesity. One method of treatment that is being
studied is administration of exogenous leptin.
Leptin is a neuropeptide that is produced by adipocytes (fat cells) and is produced in
proportion to the amount of body fat present. Leptin works on the central nervous system to reduce
appetite and increase metabolism, which is why it is being considered as a possible treatment for
obesity and metabolic syndrome [3]. Leptin lowers blood glucose in obese, diabetic mice
independently of insulin. Leptin aids in glucose uptake into brown adipose tissue and muscle [4].
Thus, leptin has potential as a therapy to treat obesity and type 2 diabetes.
Leptin acts on areas of the brain that are associated with the sympathetic nervous system
such as the hypothalamus. The arcuate nucleus (Arc) of the hypothalamus is one of the areas within
the hypothalamus with the highest concentration of leptin receptors and has projections to the
paraventricular nucleus (PVN), which has a lower expression of leptin receptors. Both the ARC
and the PVN are areas of the hypothalamus known to be involved regulating sympathetic activity
[5,6]. The efferent neurons that are activated by leptin innervate white adipose tissue and are the
pathways involved in adipocyte lipolysis [7]. Thermogenesis in brown adipose tissue also receives
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sympathetic input from the hypothalamus [8]. Central treatment with leptin has been shown to
increase sympathetic nervous system innervation in both white and brown adipose tissue, resulting
in an increase in both lipolysis and thermogenesis [9]. In both rodents and humans, the increase in
sympathetic activity caused by leptin also results in an increase in blood pressure [10]. Because
metabolic syndrome includes cardiac risk factors any increase in heart rate or blood pressure is
undesirable. To develop a safe and effective drug, it is important to understand the leptin pathways
in the brain.
The purpose of this research project was to identify potential colocalization of
metabolically-related neurons with leptin expressing neurons and to identify leptin-expressing
neurons

activated

by

exogenous

central

leptin

treatment.

We

hypothesized

that

intracerebroventricular leptin activates sympathetic metabolically-related neurons in the
hypothalamus. We tested this by using a transgenic line of mice that were created for visualization
of leptin receptor-expressing neurons through TdTomato fluorescence. To show colocalization of
metabolically-related neurons and leptin-receptor expressing neurons, we injected green
FlouSpheres into the raphe nucleus, the metabolic center of the brain. We used fluorescent
microscopy to investigate of brain sections of the hypothalamus for leptin-receptor expressing
neurons, and we used immunohistochemistry to visualize c-fos expression throughout the
hypothalamus.
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Chapter Two
Review of Literature
Epidemiology of Obesity and Metabolic syndrome
Since 1980, the prevalence of obesity has doubled, and over one-third of the world’s
population is considered obese [11]. The prevalence of obesity tends to be higher among older
(37%) and middle-aged adults (40.2%) when compared with younger adults (32.3%) [12]. Obesity
is often associated with several other clinical conditions. Metabolic syndrome refers to the group
of clinical conditions that typically coexist when combined with central and abdominal obesity.
The conditions include hypertension, insulin resistance, cardiovascular disease, kidney disease and
dyslipidemia. Data from the National Health and Nutrition Examination Survey estimates that in
the United States 35% of adults have metabolic syndrome [13]. Obesity is not an issue that is
limited to adults; 1 in 3 children are considered to be either overweight or obese, and 17.7% of
school-aged children (6-11) are considered obese. With this comes some of the same comorbidities
that are associated with obesity in adults, such as type 2 diabetes, hypertension, and fatty liver
disease. These comorbidities are the same that make up metabolic syndrome, and the presence of
these conditions in children is a good predictor of future risk of cardiovascular disease, making
childhood obesity a pressing public health problem [14,15].

Leptin and Its Role in Metabolism and Thermogenesis
Leptin is a neuropeptide that is a product of the ob gene. It is a hormone that is secreted by
adipocytes (fat cells), meaning that circulating levels of leptin are related to the amount of body
fat present. The role of leptin is to inhibit food intake and to stimulate energy expenditure. In obese
individuals, the level of circulating leptin is increased, but the increase in leptin does not result in
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a decrease in feeding activity. This has suggested that obese individuals experience resistance to
the catabolic effects of leptin [16]. Leptin also plays a role in glucose and lipid homeostasis,
reproduction, immunity, and inflammation, meaning that it has a vital role in overall body
homeostasis [17].
Leptin mediates sympathetic output to adipose tissues, regulating fat mobilization and nonshivering thermogenesis [18]. Leptin activation of the sympathetic nervous system causes lipolysis
of white adipose tissue, reducing body fat [19]. Leptin acts on the sympathetic nervous system to
activate brown adipose tissue causing thermogenesis and is suggested as a treatment for obesity
[20].
Energy Homeostasis Via the Melanocortin System
Leptin is required to maintain homeostasis of energy expenditure and body weight. Leptin
has immediate effects on the brain, acting on the hypothalamus to stimulate or inhibit appetite,
resulting in both control of behavior and control of metabolic responses [21]. Specifically, leptin
interacts with the central melanocortin system to accomplish energy regulation and glucose
homeostasis. The central melanocortin system possesses neurons that express proopiomelanocortin (POMC), which are activated by leptin and control glucose homeostasis. There
are also neurons that express agouti-related protein, which are inhibited by leptin and control food
intake and energy expenditure [22]. Neurons derived from POMC express genes that encode
another hormone called alpha-melanocyte-stimulating hormone. Alpha- MSH interacts with the
melanocortin-4-receptors (MC4R), which are located in the dorsomedial nucleus of the
hypothalamus (DMH). The interaction of alpha- MSH with MC4R decreases food or energy intake
[23]. Melanocortin receptors within the PVN are also responsible for controlling sympathetic
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output, including blood pressure and heart rate. Because of this, MC4R has been linked to
hypertension as agonists of MC4R target cholinergic neurons [24].

Leptin and Leptin receptor
For the identification of the leptin receptor (Ob-R), a cDNA library was used. The cDNAs
used encoded leptin proteins from both mice and humans and were inserted into expression
vectors. From the cDNA library, the Ob-R receptor was discovered. It is a membrane-spanning
receptor with an extracellular binding domain [25]. The long isoform of the leptin receptor (ObRb)
is the leptin receptor found within the central nervous system (CNS) [26]. The receptor for leptin
is a part of the group of class 1 cytokine receptors. The receptor for leptin (LRb) is a part of the
interleukin (IL)-6 receptor family. Receptors within this family contain an extracellular ligandbinding domain. The binding of leptin to the extracellular binding domain signals using a
noncovalently associated tyrosine kinase leads to activation of the JAK-STAT3 signaling pathway
[15]. There are six isoforms of the leptin receptor with the extracellular binding domain remaining
the same within all six isoforms while the transmembrane domains vary among the isoforms. The
LepRb intracellular domain is unique in that it has an extended intracellular signaling domain that
relies on the phosphorylation of three different tyrosine residues by activated JAK2 [27].
The receptor for leptin is expressed in the brain as well as in other tissues throughout the
body. The hypothalamus is a key area for leptin signaling and is where the majority of leptin
receptors are located [28]. The hypothalamus is an area of the brain that is instrumental in
maintaining homeostasis. It has been found that the key areas of the hypothalamus in which leptin
receptors reside are the paraventricular nucleus (PVN), arcuate nucleus (Arc), the ventromedial
hypothalamus (VMH), and the dorsomedial hypothalamus (DMH). Disruptions in leptin signaling
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within the hypothalamus are associated with obesity as leptin fails to have an effect in these cases
[29]. The activation of leptin receptors in the hypothalamus has various effects on homeostasis and
autonomic behavioral responses depending on which area is being targeted. The activation of
leptin receptors in the Arc result in the regulation of energy balance and glucose homeostasis. In
the DMH, leptin has an important role in the maintenance of body weight and thermogenesis, as
treatment with leptin has been shown to increase energy expenditure in brown adipose tissue and
increase thermogenesis. In the VMH, activation by leptin plays a role in regulating body weight
and energy homeostasis. In the PVN, leptin activates neurons that are associated with appetite [30].

Leptin Signaling
Leptin activates the JAK- STAT3 signal transduction pathway. This pathway is important
in the regulation of energy homeostasis. Pathways regulating food intake, fatty acid synthesis,
insulin secretion, and intestinal cell proliferation may also be activated upon the interaction of
leptin with its receptor [31]. When leptin interacts with an LbRb receptor, JAK is activated. The
activation of JAK phosphorylates the receptor cytoplasmic domain and results in the recruitment
of a STAT. STAT stands for signal transducer and activator of transcription, meaning that STAT
is a transcription factor that can control the expression of certain genes. The STAT3 that has been
recruited is phosphorylated at a tyrosine residue. The molecule then dimerizes and moves to the
nucleus. Once in the nucleus, STAT3 can bind to specific sequences within the genome to activate
gene expression [32]. The pSTAT3 signaling that is associated with the LbRb receptor has been
linked to changes in leptin sensitivity and the physiological state of leptin resistance as these issues
are often related to decreased leptin-activated STAT3 [33]. Specifically, STAT3 acts as a
transcription factor for a gene that is critical in feeding regulation [34].
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Leptin Receptor Expressing TdTomato Reporter Mouse
The creation of reporter mice using the Cre/lox system allows cells expressing a specific
target gene to be easily identified through fluorescence microscopy. The Cre recombinase relies
on the recognition site loxP. The Cre/lox system was originally discovered in the temperate phage
P1 and has been adapted for use in creating genetic switches that can control the expression of a
desired gene in a transgenic mouse [35]. Cre recombinase recognizes the loxP site within a DNA
fragment and excises the DNA between two directly repeated loxP sites. If the loxP sites are in an
inverted orientation, there will be an inversion of the intervening DNA instead of excision [36].
The Cre/lox system is useful in creating reporter mice that will produce fluorescence
proteins when inserted downstream of a specific target gene, eliminating the need for additional
tagging or staining. Reporter mice are created by inserting a gene that encodes for a fluorescence
protein such as TdTomato downstream of the target gene. In this study, the target gene was the
gene that encodes for the leptin receptor (OrRb). To obtain mice that express TdTomato in the
presence of expression of leptin receptors, a mouse that contains the inserted TdTomato
fluorescence gene is bred with a mouse that contains the gene for Cre driven expression of the
leptin receptor.

c-fos activation in the brain
c-fos is an intermediate early gene meaning that it is quickly expressed after cell
stimulation. Intermediate early genes are known to encode transcription factors, which alter the
expression of specific target genes. The stimulation of neurons can result in electrophysiological
activity that causes the activation of secondary messenger cascades, resulting in the production of
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transcription factors. The production of transcription factors causes the neuron’s response to
stimuli to be altered. Transcription factors bind to DNA to activate or suppress the expression of
genes [37]. The exposure of neural tissue to a depolarizing stimulus results in the expression of cfos, meaning that c-fos is an indicator of neural activity [38]. c-fos works well as an indicator of
neuronal activity due to its low level of transcription under basal conditions as low levels of c-fos
mRNA and protein have been detected under basal conditions [39]. C-fos is quickly induced upon
activation by stimuli, with the maximal levels of c-fos being present 1-3 hours after the presence
of stimuli [40].

Summary
The prevalence of metabolic syndrome and the need for more novel therapies indicate the
importance of understanding the role of leptin in neuronal pathways. A potential therapeutic for
metabolic syndrome is exogenous administration of leptin. The benefits of this would come from
leptin’s ability to increase energy expenditure and reduce appetite, but leptin is also known to
increase heart rate and blood pressure. In order to understand the peripheral effects of leptin as a
treatment for obesity, there is a need to understand the hypothalamic mechanisms involved in
metabolic input induced by leptin.
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Chapter Three
Methods
Creation of the tdTomato Reporter Mouse for ObRb
The procedures and protocols outlined below are in accord with the National Institute of
Health guidelines and were approved by the Institutional Animal Care and Use Committee at East
Tennessee State University. Adult C57BL/6 mice were bred and maintained in the animal care
facilities at ETSU in standard conditions of light (12- h light/dark cycle) and temperature (22
degrees Celsius). Reporter mice were used to visualize the presence of leptin receptor-expressing
neurons. We created the mouse line by breeding the LepRb-IRES-Cre mouse (B6,129Leprtm2(Cre)Rck./J, Jackson Laboratories) with the Cre-inducible tdTomato reporter mouse
(B6;129S6-Gt(ROSA)26Sortm9 (CAG-tdTomato) Hze/J, Jackson Laboratories). The cell bodies
and axons of leptin-receptor expressing neurons were visualized without additional staining using
this method.

Injection of Fluospheres into the Raphe for Identification of Metabolically Related Neurons
For injections into the raphe, mice were placed in a stereotaxic apparatus (Kopf
Instruments, Tujunga, CA) with the bite bar set 10.0 mm below the ear bars. Before surgery, the
dorsal surface of the head and neck were cleaned with betadine and alcohol. A 1.5 cm incision was
made in the skin over the occipital bone of the skull and the dorsal surface of the brain stem to
expose the atlantooccipital membrane. Throughout the procedure, the core body temperature was
maintained at 36-37 degrees Celsius using a servo-controlled heating lamp. A Nanoinject III
(Drummond Scientific, Broomall PA) was connected to the left anterior/posterior positioning bar
on the stereotaxic apparatus bar with a glass microinjection pipette (tip diameter 20-30 µm). The
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tip of the needle was advanced into the raphe nucleus using the following coordinates from the
obex; 0.5 mm rostral, 4.8 mm ventral, and 0 mm lateral. Fluorescent microspheres were
mechanically injected (50nl) over a 1 s period. The injections were monitored using an operating
microscope. After the Nanoinjection, the glass pipette was left in for around 1 min to ensure
complete diffusion of the Fluosphere. The location of the pipette tip and diffusion of the injectant
within the target site was examined and confirmed histologically in all mice as previously
described.

Leptin Treatment and Euthanasia
One week after the injection of Fluospheres, each mouse was treated with a 1µg dose of
leptin or saline. Leptin or saline was injected directly into the lateral ventricle. One hour postinjection of leptin, the brain and brain stem of each mouse was removed rapidly and fixed in 4%
paraformaldehyde. Cardiac paraformaldehyde perfusion was performed under isoflurane
anesthesia. This was a terminal procedure that ended in euthanasia.

Mice were initially

anesthetized in an anesthesia chamber using 4-5% isoflurane in O2. A thoracotomy was performed,
and mice were perfused through the heart and blood vessels with a 20 ml buffered saline and 20
ml fresh, buffered paraformaldehyde. A needle connected to 18” silicone tube was used to perfuse
the heart. A notch in the right atrium of the heart of the mouse allowed for the perfused saline or
paraformaldehyde to drain into a biosafety hazard-approved receptacle.
Once the brains and brain stems were removed, they were post-fixed for 12-36 hours in
paraformaldehyde followed by cryoprotection in 30% sucrose overnight. A freezing microtome
was used to section the brains and brainstems. Every third 40 µm section (120µm) from the anterior
commissure to the posterior hypothalamus was collected and stored in a 24-well plate for
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immunohistochemistry. The brain stem was also cut in 40 µm sections at the level of the raphe in
order to verify the injection site. Sections were examined for fluorescence of leptin-receptor
expressing neurons and metabolically related neurons using an Olympus BH2 microscope (Center
Valley, PA).

Immunohistochemistry for c-fos
Immunohistochemistry was performed to identify c-fos expression within the tissue
sections. First, tissue sections were rinsed with PBS four times and placed in the fridge. After a
wash period of 30 minutes, the sections were rinsed with PBS 4 times again, followed by another
30-minute wash. The sections were then placed in hydrogen peroxide at room temperature for 30
minutes. Sections were then rinsed with PBS 4 times and placed in the fridge for 30 minutes. PBS
diluent was then placed into the wells containing the sections and the sections were incubated at
room temperature for 2 hours. The primary antibody for the oncogene c-fos (rabbit anti-mouse,
Cell Signaling) was then added to the well plate. The well plate was incubated at room temperature
for 1-3 hours and was then placed in the fridge for two days.
To prepare for the secondary antibody, tissue sections were rinsed with PBS four times and
placed in the fridge. After a wash period of 30 minutes, the sections were rinsed with PBS 4 times
again, followed by another 30-minute wash period. The secondary, (DAB conjugated goat antirabbit, Jackson Lab), was then added to the well plate containing the tissue sections. Sections were
incubated at room temperature for 2 hours. Then tissue sections were washed with PBS four times
and placed in the fridge for 30 minutes and repeated. After the secondary incubation period, we
performed peroxidation of DAB to identify cFos positive neurons.
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Identification of c-fos Positive Neurons and Leptin Receptor-Expressing Neurons
Tissue sections were examined under a brightfield microscope for DAB cFos+ neurons. A
fluorescence microscope was used to identify red, fluorescent leptin receptor-expressing cells and
green, fluorescent metabolically related neurons within the hypothalamus. Sections were viewed
at 10X and 20X, with images being taken at each magnification. The images were used to count
the number of leptin receptor-expressing neurons in the paraventricular nucleus (PVN), anterior
hypothalamus (AHA), suprachiasmatic nucleus (SCN), dorsomedial hypothalamus (DMH), and
ventromedial hypothalamus (VMH). Leptin receptor-expressing neurons within the arcuate
nucleus (Arc) were not counted as the concentration of leptin receptor-expressing neurons in that
area makes it difficult to identify individual neurons. Anatomical markers were used to identify
each of the areas listed above and create prescribed boundaries for each area. Leptin receptorexpressing neurons were then counted within the prescribed boundaries for each area. Tissue
sections were then examined under a brightfield microscope to identify c-fos expressing neurons.
The sections were examined at both 10 and 20X magnification. Images of the 20X magnification
were used to count c-fos positive neurons. The same prescribed areas were used as boundary
markers to identify and count neurons within the PVN, AHA, SCN, DMH, VMH, and Arc.
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Chapter Four
Results
Fluorescent neurons expressing leptin-receptors were identified in the brains of tdTomato
mice throughout the hypothalamus. There was robust expression of leptin-receptor expressing
neurons in the DMH, VMH, and Arc (Fig 1).
The expression of the early gene c-fos was then identified throughout the hypothalamus of
mice treated with either saline or leptin. Compared with saline-treated mice, leptin appeared to
augment cFos within the PVN, AHA, DMH, SCN and Arc (Fig 2). In leptin- treated mice the mean
number of cFos+ neurons was 38 in the PVN, 41 in the AHA, 46 in the SCN, 63 in the DMH, 29
in the VMH, and 40 in the Arc. In saline-treated mice, the mean number of cFos+ neurons was 14
in the PVN, 27 in the AHA, 26 in the SCN, 50 in the DMH, 17 in the VMH, and 22 in the Arc.
We determined how many leptin receptor-expressing neurons also expressed c-fos in the
areas of the hypothalamus where leptin receptors were most robustly expressed. In the DMH,
treatment by exogenous leptin produced 2 co-labeled neurons, while treatment by saline resulted
in 5 co-labeled neurons. In the VMH, treatment by exogenous leptin produced 2 co-labeled
neurons, while treatment by saline resulted in no co-labeled neurons. In the Arc, treatment by
exogenous leptin produced 5 co-labeled neurons, while treatment by saline resulted in 2 co-labeled
neurons.
To determine if intracerebroventricular (icv) leptin treatment activated metabolicallyrelated DMH neurons, we combined retrograde anatomical tracing and cFos activation after leptin
treatment. A representative image of retrogradely labelled raphe-projecting (metabolicallysensitive) leptin receptor-positive TdTomato expressing neurons are shown in Fig 4. While icv
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leptin administration induced cFos+ neurons within the DMH, co-labelling of cFos and
retrogradely labelled or leptin receptor expressing neurons are sparse.
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Chapter Five
Discussion
Leptin receptor-expressing neurons have been identified throughout the hypothalamus in
areas such as the Arc, DMH, VMH, and PVN [41]. In accordance with this, we noted the presence
of leptin receptors throughout the hypothalamus using our ObRB- tdTomato reporter mouse. The
most robust expression of leptin receptor-expressing neurons was found in the posterior
hypothalamus in the areas of the Arc, DMH, and the VMH, .
The hypothalamus is the area of the brain responsible for coordinating homeostatic systems
[42]. The DMH is involved in homeostasis of energy expenditure and thermogenesis [29]. The
raphe nucleus of the brain stem receives input from the DMH and is considered to be the metabolic
center [43]. The presympathetic neurons of the raphe have spinal projections that synapse on
sympathetic preganglionic neurons that control the metabolic activity and thermogenesis within
brown adipose tissue [44]. It has been shown that when neurons in the DMH are activated by a
stimulus such as corticotropin releasing factor there is an increase in brown adipose tissue
sympathetic nerve activity and thermogenesis, expired carbon dioxide, and heart rate [45]. Thus,
the neurons that project to the raphe are considered to be thermogenic and metabolically related.
Using a microinjection technique to introduce GABA to the hypothalamus, we have also seen an
increase in renal sympathetic nerve activity, suggesting that the neurons of the raphe also play a
role in the maintenance of blood pressure [46]. This is why we focused on the activation of leptinreceptor- expressing neurons within the raphe-projecting neurons or metabolically related neurons
of the DMH. We identified the metabolically-related neurons through retrograde labeling then
used DAB immunohistochemistry to stain brain sections for c-fos, which is a marker of neuronal
activation. Upon examining for co-labeled of retrogradely labeled leptin receptor-expressing
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neurons and c-fos labeled neurons, we found that there was no colocalization, suggesting that
leptin treatment did not activate the metabolic center.
Research by Hermann, Barnes, and Rogers in 2006 suggests that leptin may not act alone
to activate thermogenesis in brown adipose tissue. They found that leptin alone had no effect on
thermogenesis within brown adipose tissue and that there was a change in thermogenesis when
leptin was introduced alongside thyrotropin-releasing hormone. Thyrotropin-releasing hormone is
a stimulus that results in thermogenesis, so this suggests that leptin may not act alone to induce
thermogenesis but rather increase the efficacy of other signals that generate thermogenesis [47].
The results of the 2006 study may act as an explanation of why we did not see activation of the
metabolic center when leptin was introduced as a treatment.
The goal of obesity treatment is to reduce the cardiovascular risk factors and to diminish
metabolic syndrome-related comorbidities. Because of this, one goal of a treatment for obesity
would be to avoid the activation of neurons that cause increases in heart rate and blood pressure
as these issues are associated with cardiovascular disease. In order to gain a better understanding
of the activation of metabolically related neurons in the DMH in response to treatment with leptin,
this study should be repeated with a larger sample size.
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Figure Legends

Figure 1: Figure shows leptin receptor-expressing neurons within the hypothalamus. Flourescent
photomicrographs (4X and 10X) showing leptin tdTomato labeled neurons in the dorsomedial
(DMH), ventromedial (VMH), and arcuate nucleus (Arc) of the hypothalamus in ObRb-IRES-CretdTomato mouse brain (A). Graphs showing leptin receptor tdTomato labeled neurons within the
paraventricular nucleus (PVN), anterior hypothalamus (AHA), suprachiasmatic nucleus (SCN),
ventromedial hypothalamus (VMH), and dorsomedial hypothalamus (DMH) (n=5) (B).

Figure 2: Images showing c-fos expression throughout the hypothalamus. Photomicrograph (10X
and 20X) showing c-fos expressing neurons in the rostral portion of the hypothalamus of a salinetreated mouse (A). Photomicrograph (10X and 20X) showing c-fos expressing neurons in the
rostral portion of the hypothalamus of a leptin-treated mouse (B). Photomicrograph (10X and 20X)
showing c-fos expressing neurons in the caudal portion of the hypothalamus of a saline-treated
mouse (C). Photomicrograph (10X and 20X) showing c-fos expressing neurons in the caudal
portion of the hypothalamus of a leptin-treated mouse (D).

Figure 3: Summary graphs showing c-fos expressing neurons in mice treated with icv vehicle (n=2)
compared with mice treated with icv leptin (1 µg, n=4) within the paraventricular nucleus (A),
anterior hypothalamus (B), suprachiasmatic nucleus (C), dorsomedial hypothalamus (D),
ventromedial hypothalamus (E), and the arcuate nucleus (F).
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Figure 4: Images showing neurons within the hypothalamus that express the leptin receptor (red),
raphe-projecting retrogradely labelled neurons (green) and leptin-induced cFos positive neurons.
Anatomical map of the hypothalamus (A). Leptin receptor-expressing neurons within the
hypothalamus (B). Metabolic-related neurons within the dorsomedial hypothalamus (C). c-fos
positive neurons within the hypothalamus (D). Merged image showing leptin receptor-expressing
neurons with metabolic-related neurons (E). Merged image showing leptin receptor-expressing
neurons, metabolic-related neurons, and c-fos positive neurons (F).
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